{"entity":{"type":"insider","cik":"0002004379","url":"/insider/0002004379","json_url":"/insider/0002004379.json","name":"Kooij Louise Frederika","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":12,"first":"2024-10-01","last":"2026-07-22","span_basis":"filed_date"},"name_variants":[{"name":"Kooij Louise Frederika","source":"filing","n_filings":12,"first_seen":"2024-10-01","last_seen":"2026-07-22"}],"transactions":[{"id":5825831,"accession":"0001193125-26-312387","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-26-312387","line_url":"/filing/0001193125-26-312387","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105000.0,"shares_display":"105,000","price_per_share":30.33958,"price_display":"30.34","price_state":"stated","total_value":3185655.9,"total_display":"3,185,655.90","total_whole":"3,185,656","shares_owned_after":59153.0,"shares_owned_after_display":"59,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-20","filed_date":"2026-07-22","scope":"insider","n_lines":3},{"id":6073676,"accession":"0001193125-26-281062","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-281062","line_url":"/filing/0001193125-26-281062","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":30.203975,"price_display":"30.20","price_state":"stated","total_value":1208159.0,"total_display":"1,208,159.00","total_whole":"1,208,159","shares_owned_after":24653.0,"shares_owned_after_display":"24,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider","n_lines":2},{"id":5751224,"accession":"0001193125-26-241983","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-241983","line_url":"/filing/0001193125-26-241983#line-3","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65000.0,"shares_display":"65,000","price_per_share":35.69,"price_display":"35.69","price_state":"stated","total_value":2319850.0,"total_display":"2,319,850.00","total_whole":"2,319,850","shares_owned_after":24353.0,"shares_owned_after_display":"24,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-26","filed_date":"2026-05-27","scope":"insider"},{"id":6016021,"accession":"0001193125-26-029526","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-029526","line_url":"/filing/0001193125-26-029526#line-4","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32612.0,"shares_display":"32,612","price_per_share":31.8,"price_display":"31.80","price_state":"stated","total_value":1037061.6,"total_display":"1,037,061.60","total_whole":"1,037,062","shares_owned_after":24353.0,"shares_owned_after_display":"24,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-28","filed_date":"2026-01-29","scope":"insider"},{"id":6016015,"accession":"0001193125-26-029526","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-029526","line_url":"/filing/0001193125-26-029526#line-2","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39816.0,"shares_display":"39,816","price_per_share":32.62,"price_display":"32.62","price_state":"stated","total_value":1298797.92,"total_display":"1,298,797.92","total_whole":"1,298,798","shares_owned_after":24353.0,"shares_owned_after_display":"24,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-27","filed_date":"2026-01-29","scope":"insider"},{"id":6072520,"accession":"0001193125-26-025012","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-26-025012","line_url":"/filing/0001193125-26-025012","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34400.0,"shares_display":"34,400","price_per_share":32.776108139534884,"price_display":"32.78","price_state":"stated","total_value":1127498.12,"total_display":"1,127,498.12","total_whole":"1,127,498","shares_owned_after":24662.0,"shares_owned_after_display":"24,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-26","filed_date":"2026-01-27","scope":"insider","n_lines":2},{"id":6072512,"accession":"0001193125-26-025012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-025012","line_url":"/filing/0001193125-26-025012","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38172.0,"shares_display":"38,172","price_per_share":33.75104762653254,"price_display":"33.75","price_state":"stated","total_value":1288344.99,"total_display":"1,288,344.99","total_whole":"1,288,345","shares_owned_after":37120.0,"shares_owned_after_display":"37,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-23","filed_date":"2026-01-27","scope":"insider","n_lines":2},{"id":6152189,"accession":"0001193125-26-006659","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-006659","line_url":"/filing/0001193125-26-006659#line-1","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2647.0,"shares_display":"2,647","price_per_share":33.25,"price_display":"33.25","price_state":"stated","total_value":88012.75,"total_display":"88,012.75","total_whole":"88,013","shares_owned_after":12353.0,"shares_owned_after_display":"12,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-07","scope":"insider"},{"id":4880500,"accession":"0001193125-25-335513","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193125-25-335513","line_url":"/filing/0001193125-25-335513#line-7","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43872.0,"shares_display":"43,872","price_per_share":35.3,"price_display":"35.30","price_state":"stated","total_value":1548681.6,"total_display":"1,548,681.60","total_whole":"1,548,682","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-26","filed_date":"2025-12-29","scope":"insider"},{"id":4880490,"accession":"0001193125-25-335513","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-335513","line_url":"/filing/0001193125-25-335513#line-4","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26011.0,"shares_display":"26,011","price_per_share":35.68,"price_display":"35.68","price_state":"stated","total_value":928072.48,"total_display":"928,072.48","total_whole":"928,072","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-24","filed_date":"2025-12-29","scope":"insider"},{"id":4880483,"accession":"0001193125-25-335513","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-335513","line_url":"/filing/0001193125-25-335513#line-2","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75117.0,"shares_display":"75,117","price_per_share":36.21,"price_display":"36.21","price_state":"stated","total_value":2719986.57,"total_display":"2,719,986.57","total_whole":"2,719,987","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-23","filed_date":"2025-12-29","scope":"insider"},{"id":4027981,"accession":"0000950170-25-114033","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-114033","line_url":"/filing/0000950170-25-114033","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":25.826778666666666,"price_display":"25.83","price_state":"stated","total_value":3874016.8,"total_display":"3,874,016.80","total_whole":"3,874,017","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-09","filed_date":"2025-09-10","scope":"insider","n_lines":2},{"id":5076218,"accession":"0000950170-25-113276","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-113276","line_url":"/filing/0000950170-25-113276#line-1","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18073.0,"shares_display":"18,073","price_per_share":25.09,"price_display":"25.09","price_state":"stated","total_value":453451.57,"total_display":"453,451.57","total_whole":"453,452","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-03","filed_date":"2025-09-05","scope":"insider"},{"id":4133399,"accession":"0000950170-25-111738","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-111738","line_url":"/filing/0000950170-25-111738#line-1","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8269.0,"shares_display":"8,269","price_per_share":24.86,"price_display":"24.86","price_state":"stated","total_value":205567.34,"total_display":"205,567.34","total_whole":"205,567","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-27","scope":"insider"},{"id":4791086,"accession":"0000950170-25-033927","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-033927","line_url":"/filing/0000950170-25-033927#line-2","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":20.37,"price_display":"20.37","price_state":"stated","total_value":3055500.0,"total_display":"3,055,500.00","total_whole":"3,055,500","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-05","scope":"insider"},{"id":2515915,"accession":"0000950170-24-110955","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-110955","line_url":"/filing/0000950170-24-110955#line-2","is_derivative":false,"issuer_cik":"0001936258","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001936258","owner_cik":"0002004379","owner_name":"Kooij Louise Frederika","owner_display_name":"Kooij Louise Frederika","owner_url":"/insider/0002004379","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":15.72,"price_display":"15.72","price_state":"stated","total_value":707400.0,"total_display":"707,400.00","total_whole":"707,400","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001936258","name":"NewAmsterdam Pharma Co N.V.","url":"/issuer/0001936258","role":"Officer (Chief Accounting Officer)","n_filings":12,"first_seen":"2024-10-01","last_seen":"2026-07-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002004379","retrieved_at":"2026-08-24T20:26:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}